Neo Millicent Tapela, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Botswana | 14 | 2024 | 1056 | 0.670 |
Why?
|
Blood Pressure | 4 | 2023 | 8531 | 0.580 |
Why?
|
Hypertension | 5 | 2023 | 8615 | 0.520 |
Why?
|
Hypercholesterolemia | 1 | 2022 | 1144 | 0.480 |
Why?
|
Rwanda | 14 | 2018 | 671 | 0.480 |
Why?
|
Antihypertensive Agents | 2 | 2021 | 2030 | 0.450 |
Why?
|
Neoplasms | 13 | 2022 | 22350 | 0.450 |
Why?
|
Cholesterol, LDL | 1 | 2022 | 2392 | 0.410 |
Why?
|
World Health Organization | 1 | 2018 | 1327 | 0.400 |
Why?
|
Delivery of Health Care | 4 | 2016 | 5363 | 0.360 |
Why?
|
Health Personnel | 3 | 2019 | 3387 | 0.260 |
Why?
|
Program Development | 4 | 2019 | 1298 | 0.240 |
Why?
|
Hospitals, District | 3 | 2019 | 114 | 0.210 |
Why?
|
Primary Health Care | 2 | 2022 | 4746 | 0.210 |
Why?
|
HIV Infections | 8 | 2024 | 17542 | 0.210 |
Why?
|
Uterine Cervical Neoplasms | 3 | 2022 | 2038 | 0.210 |
Why?
|
Cardiovascular Diseases | 3 | 2024 | 15645 | 0.200 |
Why?
|
Rural Population | 4 | 2017 | 2321 | 0.200 |
Why?
|
Patient Acceptance of Health Care | 1 | 2016 | 3232 | 0.190 |
Why?
|
Myocardial Infarction | 1 | 2022 | 11513 | 0.180 |
Why?
|
Developing Countries | 6 | 2023 | 2911 | 0.180 |
Why?
|
Multilevel Analysis | 1 | 2019 | 148 | 0.150 |
Why?
|
Medication Reconciliation | 1 | 2020 | 153 | 0.150 |
Why?
|
Apolipoprotein E4 | 1 | 2022 | 709 | 0.140 |
Why?
|
Health Policy | 4 | 2019 | 2698 | 0.140 |
Why?
|
Rheumatic Heart Disease | 1 | 2018 | 163 | 0.140 |
Why?
|
Antineoplastic Agents | 2 | 2018 | 13650 | 0.130 |
Why?
|
Organizational Objectives | 1 | 2018 | 426 | 0.130 |
Why?
|
Benchmarking | 1 | 2022 | 1056 | 0.130 |
Why?
|
Rural Health | 1 | 2017 | 302 | 0.130 |
Why?
|
Wilms Tumor | 1 | 2018 | 378 | 0.130 |
Why?
|
Capacity Building | 1 | 2018 | 265 | 0.120 |
Why?
|
Infant Nutritional Physiological Phenomena | 1 | 2017 | 352 | 0.120 |
Why?
|
Schools, Medical | 2 | 2018 | 883 | 0.120 |
Why?
|
Rural Health Services | 2 | 2017 | 393 | 0.120 |
Why?
|
Evidence-Based Practice | 1 | 2019 | 499 | 0.120 |
Why?
|
Cancer Care Facilities | 1 | 2017 | 427 | 0.110 |
Why?
|
Adult | 18 | 2024 | 223317 | 0.110 |
Why?
|
Bronchodilator Agents | 1 | 2017 | 513 | 0.110 |
Why?
|
Medication Errors | 1 | 2020 | 784 | 0.110 |
Why?
|
Ambulatory Care Facilities | 1 | 2020 | 939 | 0.110 |
Why?
|
Middle Aged | 18 | 2024 | 223233 | 0.110 |
Why?
|
Risk Factors | 7 | 2024 | 74886 | 0.110 |
Why?
|
Female | 25 | 2024 | 396660 | 0.110 |
Why?
|
Personal Satisfaction | 1 | 2017 | 643 | 0.110 |
Why?
|
Humans | 38 | 2024 | 767040 | 0.110 |
Why?
|
Infant, Low Birth Weight | 1 | 2017 | 871 | 0.100 |
Why?
|
Anti-Asthmatic Agents | 1 | 2017 | 572 | 0.100 |
Why?
|
Breast Neoplasms | 4 | 2024 | 21178 | 0.100 |
Why?
|
Male | 19 | 2024 | 364203 | 0.100 |
Why?
|
Prevalence | 4 | 2023 | 15851 | 0.100 |
Why?
|
International Cooperation | 1 | 2018 | 1434 | 0.090 |
Why?
|
Health Services Accessibility | 4 | 2017 | 5519 | 0.090 |
Why?
|
Hodgkin Disease | 1 | 2018 | 1383 | 0.090 |
Why?
|
Cisplatin | 1 | 2016 | 1656 | 0.090 |
Why?
|
Papillomavirus Infections | 1 | 2022 | 1639 | 0.090 |
Why?
|
Mammography | 1 | 2021 | 2431 | 0.080 |
Why?
|
Forecasting | 1 | 2018 | 2936 | 0.080 |
Why?
|
Nutritional Status | 1 | 2017 | 1628 | 0.080 |
Why?
|
Brachytherapy | 1 | 2016 | 1220 | 0.080 |
Why?
|
Medication Adherence | 1 | 2020 | 2191 | 0.070 |
Why?
|
Infant, Premature | 1 | 2017 | 2125 | 0.070 |
Why?
|
Cross-Sectional Studies | 4 | 2024 | 26325 | 0.070 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2015 | 951 | 0.070 |
Why?
|
Aged | 8 | 2021 | 171319 | 0.070 |
Why?
|
Quality of Health Care | 2 | 2018 | 4306 | 0.070 |
Why?
|
Education, Medical | 1 | 2018 | 1746 | 0.070 |
Why?
|
Healthcare Disparities | 2 | 2019 | 3414 | 0.060 |
Why?
|
Child Development | 1 | 2017 | 2329 | 0.060 |
Why?
|
Referral and Consultation | 4 | 2022 | 3618 | 0.060 |
Why?
|
Medical Oncology | 1 | 2015 | 2341 | 0.050 |
Why?
|
Adolescent | 5 | 2019 | 89046 | 0.050 |
Why?
|
Poverty | 1 | 2014 | 2719 | 0.050 |
Why?
|
Cardiac Surgical Procedures | 1 | 2018 | 3683 | 0.050 |
Why?
|
Quality of Life | 1 | 2024 | 13485 | 0.050 |
Why?
|
Palliative Care | 1 | 2017 | 3641 | 0.050 |
Why?
|
Socioeconomic Factors | 1 | 2016 | 7848 | 0.050 |
Why?
|
Clinical Competence | 1 | 2017 | 4859 | 0.050 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39317 | 0.050 |
Why?
|
Treatment Outcome | 4 | 2022 | 65295 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2019 | 7435 | 0.050 |
Why?
|
Models, Biological | 1 | 2016 | 9464 | 0.040 |
Why?
|
Prospective Studies | 2 | 2021 | 54886 | 0.040 |
Why?
|
Early Detection of Cancer | 3 | 2022 | 3236 | 0.040 |
Why?
|
Survival Rate | 3 | 2018 | 12823 | 0.040 |
Why?
|
Policy | 1 | 2022 | 513 | 0.040 |
Why?
|
Electronic Health Records | 1 | 2016 | 4881 | 0.040 |
Why?
|
Asthma | 1 | 2017 | 6268 | 0.040 |
Why?
|
Personnel Loyalty | 1 | 2017 | 11 | 0.040 |
Why?
|
Health Resources | 2 | 2014 | 948 | 0.040 |
Why?
|
Neoplasm Staging | 3 | 2019 | 11217 | 0.040 |
Why?
|
Program Evaluation | 2 | 2017 | 2505 | 0.040 |
Why?
|
Health Facilities | 1 | 2022 | 578 | 0.040 |
Why?
|
Internship and Residency | 1 | 2017 | 5947 | 0.040 |
Why?
|
Young Adult | 3 | 2019 | 59980 | 0.030 |
Why?
|
Apolipoproteins E | 1 | 2022 | 1459 | 0.030 |
Why?
|
Africa | 1 | 2018 | 725 | 0.030 |
Why?
|
Disease-Free Survival | 2 | 2016 | 6844 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2016 | 11872 | 0.030 |
Why?
|
Income | 1 | 2023 | 1877 | 0.030 |
Why?
|
Retrospective Studies | 6 | 2021 | 81659 | 0.030 |
Why?
|
Drug Utilization | 1 | 2020 | 1190 | 0.030 |
Why?
|
Hospitals, Rural | 1 | 2015 | 174 | 0.030 |
Why?
|
CD4 Lymphocyte Count | 1 | 2019 | 2586 | 0.030 |
Why?
|
Morbidity | 1 | 2018 | 1754 | 0.030 |
Why?
|
Medically Underserved Area | 1 | 2014 | 268 | 0.020 |
Why?
|
Self Report | 1 | 2024 | 3773 | 0.020 |
Why?
|
Needs Assessment | 1 | 2018 | 1141 | 0.020 |
Why?
|
Models, Organizational | 1 | 2015 | 548 | 0.020 |
Why?
|
Child Mortality | 1 | 2014 | 204 | 0.020 |
Why?
|
Costs and Cost Analysis | 1 | 2017 | 1666 | 0.020 |
Why?
|
Policy Making | 1 | 2015 | 546 | 0.020 |
Why?
|
Delayed Diagnosis | 1 | 2015 | 454 | 0.020 |
Why?
|
Drug Prescriptions | 1 | 2020 | 1664 | 0.020 |
Why?
|
Viral Load | 1 | 2019 | 3385 | 0.020 |
Why?
|
Child, Preschool | 3 | 2018 | 42606 | 0.020 |
Why?
|
Health Expenditures | 1 | 2022 | 2390 | 0.020 |
Why?
|
Population Surveillance | 1 | 2019 | 2594 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2015 | 1512 | 0.020 |
Why?
|
Inpatients | 1 | 2019 | 2563 | 0.020 |
Why?
|
Health Surveys | 1 | 2017 | 4056 | 0.020 |
Why?
|
Genotype | 1 | 2022 | 13035 | 0.020 |
Why?
|
Health Services Needs and Demand | 1 | 2015 | 1405 | 0.020 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2014 | 836 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2022 | 14672 | 0.020 |
Why?
|
Tuberculosis | 1 | 2019 | 2011 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2016 | 6513 | 0.020 |
Why?
|
Time Factors | 2 | 2019 | 40154 | 0.020 |
Why?
|
Sex Factors | 1 | 2019 | 10622 | 0.020 |
Why?
|
Mass Screening | 1 | 2021 | 5456 | 0.010 |
Why?
|
Infant | 2 | 2017 | 36485 | 0.010 |
Why?
|
Pilot Projects | 1 | 2017 | 8732 | 0.010 |
Why?
|
Patient Care Team | 1 | 2015 | 2516 | 0.010 |
Why?
|
Child | 3 | 2018 | 80771 | 0.010 |
Why?
|
Comorbidity | 1 | 2016 | 10582 | 0.010 |
Why?
|
Hospitals | 1 | 2015 | 3883 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2016 | 12536 | 0.010 |
Why?
|
Logistic Models | 1 | 2016 | 13284 | 0.010 |
Why?
|
Analgesics, Opioid | 1 | 2017 | 3837 | 0.010 |
Why?
|
Hospitalization | 1 | 2019 | 10815 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2017 | 15925 | 0.010 |
Why?
|
Risk Assessment | 1 | 2020 | 24299 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2017 | 26396 | 0.010 |
Why?
|
Prognosis | 1 | 2018 | 29963 | 0.010 |
Why?
|
Cohort Studies | 1 | 2017 | 41718 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2016 | 59548 | 0.010 |
Why?
|